Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business

Amplitude Vascular Systems has been acquired by Stryker Corporation for up to $835 million, highlighting continued consolidation in medical technology. The deal is positive for BioStar Capital and suggests strategic value in the vascular-device space. The announcement is notable for the involved companies but is unlikely to have broad market impact.

Analysis

Amplitude Vascular Systems has been acquired by Stryker Corporation for up to $835 million, highlighting continued consolidation in medical technology. The deal is positive for BioStar Capital and suggests strategic value in the vascular-device space. The announcement is notable for the involved companies but is unlikely to have broad market impact.